Pentwater Capital Management Reduces $86M in Kenvue Inc. ($KVUE)

Key Points

  • Pentwater Capital Management changed its Kenvue Inc. ($KVUE) stake by 8.3% last quarter, cutting to 52,000,000 shares worth $943.59 million.
  • $KVUE last traded around $18.15.

Pentwater Capital Management trimmed its position in Kenvue Inc. ($KVUE) by 8.3% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 52,000,000 shares of Kenvue Inc. after selling 4,720,600 shares during the quarter. Pentwater Capital Management's holdings in Kenvue Inc. were worth $943.59 million as of its most recent filing.

Kenvue Inc. ($KVUE) Stock

Last price$18.15
Market cap$34.83B
P/E ratio21.60
Forward P/E14.67
PEG ratio1.52
Beta0.50
52-week low$14.02
52-week high$22.87
50-day MA$17.42
200-day MA$17.32
Current ratio0.98
Quick ratio0.61
Debt-to-equity0.83

Kenvue Inc. Earnings

EPS (ttm)$0.84
Revenue (ttm)$15.29B
Revenue growth4.5%
Net margin10.6%
Return on equity15.7%
Next earningsAug 6, 2026

Kenvue Inc. Dividend

Annual dividend$0.83
Dividend yield458.00%
Payout ratio98.5%
Ex-dividend dateMay 13, 2026

Analysts Set New Price Targets

Average target$19.50
High target$23.00
Low target$18.00
Analysts covering12

About Kenvue Inc.

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

ExchangeNYSE
SectorConsumer Defensive
IndustryHousehold & Personal Products
HeadquartersSummit, NJ
CEOMr. Kirk L. Perry
Employees21,780

See Also

This instant news alert was generated by automated narrative technology and financial data from Trueearnings and public regulatory filings. It is for informational purposes only and is not financial advice.